These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9019300)

  • 21. Induced circular dichroism spectra reveal binding of the antiinflammatory curcumin to human alpha1-acid glycoprotein.
    Zsila F; Bikádi Z; Simonyi M
    Bioorg Med Chem; 2004 Jun; 12(12):3239-45. PubMed ID: 15158792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of antihistamine-human serum protein interactions by capillary electrophoresis.
    Martínez-Gómez MA; Carril-Avilés MM; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    J Chromatogr A; 2007 Apr; 1147(2):261-9. PubMed ID: 17339039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin.
    Schönfeld DL; Ravelli RB; Mueller U; Skerra A
    J Mol Biol; 2008 Dec; 384(2):393-405. PubMed ID: 18823996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of desialylation on human α1-acid glycoprotein-ligand interactions.
    Huang RY; Hudgens JW
    Biochemistry; 2013 Oct; 52(40):7127-36. PubMed ID: 24041412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatographic modelling of interactions between melanin and phenothiazine and dibenzazepine drugs.
    Radwańska A; Frackowiak T; Ibrahim H; Aubry AF; Kaliszan R
    Biomed Chromatogr; 1995; 9(5):233-7. PubMed ID: 8593425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural properties governing drug-plasma protein binding determined by high-performance liquid chromatography method.
    Kamble S; Loadman P; Abraham MH; Liu X
    J Pharm Biomed Anal; 2018 Feb; 149():16-21. PubMed ID: 29100026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
    Huang Z; Ung T
    Curr Drug Metab; 2013 Feb; 14(2):226-38. PubMed ID: 23092311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A site-directed mutagenesis study of drug-binding selectivity in genetic variants of human alpha(1)-acid glycoprotein.
    Nishi K; Ueno M; Murakami Y; Fukunaga N; Akuta T; Kadowaki D; Watanabe H; Suenaga A; Maruyama T; Otagiri M
    J Pharm Sci; 2009 Nov; 98(11):4316-26. PubMed ID: 19198000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein.
    Gokara M; Kimavath GB; Podile AR; Subramanyam R
    J Biomol Struct Dyn; 2015; 33(1):196-210. PubMed ID: 24359035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retention of barbituric acid derivatives on immobilized artificial membrane stationary phase and its correlation with biological activity.
    Kepczyńska E; Bojarski J; Haber P; Kaliszan R
    Biomed Chromatogr; 2000 Jun; 14(4):256-60. PubMed ID: 10861737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-1-acid glycoprotein.
    Fournier T; Medjoubi-N N; Porquet D
    Biochim Biophys Acta; 2000 Oct; 1482(1-2):157-71. PubMed ID: 11058758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of drug interactions with alpha
    Bi C; Matsuda R; Zhang C; Isingizwe Z; Clarke W; Hage DS
    J Chromatogr A; 2017 Oct; 1519():64-73. PubMed ID: 28886937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention of quinolones on human serum albumin and alpha1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity.
    Barbato F; di Martino G; Grumetto L; La Rotonda MI
    Eur J Pharm Sci; 2007 Mar; 30(3-4):211-9. PubMed ID: 17169537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of quinaldine red as a fluorescent probe for studies of drug-alpha 1-acid glycoprotein interaction.
    Imamura H; Maruyama T; Otagiri M
    Biol Pharm Bull; 1993 Sep; 16(9):926-9. PubMed ID: 8268861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using α1-acid glycoprotein microcolumns.
    Bi C; Zheng X; Hage DS
    J Chromatogr A; 2016 Feb; 1432():49-57. PubMed ID: 26797422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of ligand binding on structure and thermostability of human α1-acid glycoprotein.
    Kopecký V; Ettrich R; Pazderka T; Hofbauerová K; Řeha D; Baumruk V
    J Mol Recognit; 2016 Feb; 29(2):70-9. PubMed ID: 26400697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of phenothiazines on the binding of [3H]perazine to alpha 1-acid glycoprotein.
    Schley J
    J Pharm Pharmacol; 1987 Feb; 39(2):132-4. PubMed ID: 2881999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilization of the Karenitecin® lactone by alpha-1 acid glycoprotein.
    Yao S; Petluru P; Parker A; Ding D; Chen X; Huang Q; Kochat H; Hausheer F
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):719-28. PubMed ID: 25634596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing the binding of propranolol enantiomers to alpha1-acid glycoprotein with ligand-detected NMR experiments.
    Becker BA; Larive CK
    J Phys Chem B; 2008 Oct; 112(43):13581-7. PubMed ID: 18839985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid.
    Brunner F; Müller WE
    J Pharm Pharmacol; 1985 May; 37(5):305-9. PubMed ID: 2862237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.